Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
[Pharmacotherapy for children and adolescents with sleep disorders: an overview]
Katharina Grau1, Paul L Plener1
11 Klinik für Kinder- und Jugendpsychiatrie/-psychotherapie, Universitätsklinikum Ulm.
Insights
Pharmacotherapy for pediatric sleep disorders is considered when non-drug approaches fail. Melatonin shows promise for children with autism spectrum disorder, but evidence for other medications is limited, favoring non-drug treatments.
Area of Science:
- Pediatric Sleep Medicine
- Child and Adolescent Psychiatry
- Pharmacology
Background:
- Sleep difficulties affect approximately 20% of children and adolescents.
- Insomnia in minors leads to reduced psychosocial functioning and significant distress.
- Effective treatment strategies are crucial for this population.
Purpose of the Study:
- To provide a literature overview on pharmacotherapy for sleep disorders in children and adolescents.
- To evaluate the evidence for different substance classes in hypnotic indications.
- To guide clinical decision-making regarding medication use.
Main Methods:
- Literature review of studies on pharmacotherapy for pediatric sleep disorders.
- Analysis of substance classes used for hypnotic indications in minors.
- Examination of evidence for efficacy and tolerability.
Main Results:
- Melatonin has demonstrated positive effects on sleep in children and adolescents with autism spectrum disorder.
- Limited evidence exists for the efficacy and tolerability of other medications in primary insomnia or sleep disorders in minors with psychiatric conditions.
- Non-drug treatment strategies are preferred.
Conclusions:
- Non-drug interventions for sleep disorders in children and adolescents should be prioritized.
- Pharmacotherapy should only be considered as a secondary option after careful evaluation.
- Further research is needed on the efficacy and safety of various medications in pediatric populations.
Abstract:
Pharmacotherapy for children and adolescents with sleep disorders: an overview Abstract. Sleep difficulties are a relevant symptom in childhood and adolescence with a prevalence of approximately 20 %. Because of the reduced psychosocial functioning and the burden of suffering associated with insomnia, effective treatment strategies are needed. If interventions such as the implementation of an adequate sleep hygiene and other non-drug treatment approaches are not sufficient, pharmacotherapeutic treatment is often considered. The present work provides a literature overview on the use of different substance classes in hypnotic indications. The use of melatonin in children and adolescents with autism spectrum disorder has been well studied and is associated with a positive effect on sleep in this patient group. To date, there is little evidence regarding the efficacy and tolerability of other medication in primary insomnia or sleep disorders in the context of other psychiatric disorders in minors. For this reason, non-drug treatment strategies are preferred and pharmacotherapy is only to be considered secondarily after critical examination.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Drug Therapy
Antianxiety Medications
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...